Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Xometry, Inc. (NASDAQ:XMTR - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 39,144 shares of the company's stock, valued at approximately $975,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.08% of Xometry as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of XMTR. First Trust Advisors LP increased its stake in shares of Xometry by 2,144.2% during the 4th quarter. First Trust Advisors LP now owns 817,475 shares of the company's stock worth $34,873,000 after purchasing an additional 781,049 shares during the last quarter. Ameriprise Financial Inc. grew its stake in Xometry by 225.7% in the 4th quarter. Ameriprise Financial Inc. now owns 852,813 shares of the company's stock valued at $36,381,000 after buying an additional 590,974 shares during the last quarter. Lord Abbett & CO. LLC acquired a new position in Xometry in the 4th quarter valued at $17,623,000. Driehaus Capital Management LLC acquired a new position in Xometry in the 4th quarter valued at $16,551,000. Finally, Polar Capital Holdings Plc acquired a new position in Xometry in the 4th quarter valued at $14,070,000. Institutional investors and hedge funds own 97.31% of the company's stock.
Xometry Price Performance
XMTR traded down $0.43 during midday trading on Wednesday, hitting $43.85. The company had a trading volume of 1,201,162 shares, compared to its average volume of 706,791. The company has a debt-to-equity ratio of 0.91, a quick ratio of 3.70 and a current ratio of 3.74. The company has a market capitalization of $2.22 billion, a PE ratio of -44.39 and a beta of 0.83. Xometry, Inc. has a twelve month low of $11.33 and a twelve month high of $47.46. The firm's 50-day simple moving average is $33.52 and its 200-day simple moving average is $30.40.
Xometry (NASDAQ:XMTR - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.09 EPS for the quarter, topping the consensus estimate of $0.05 by $0.04. The company had revenue of $162.55 million during the quarter, compared to analysts' expectations of $156.53 million. Xometry had a negative net margin of 8.52% and a negative return on equity of 8.30%. Xometry's revenue was up 22.6% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.01) EPS. Equities research analysts predict that Xometry, Inc. will post -0.66 EPS for the current fiscal year.
Insiders Place Their Bets
In other news, Director Emily Rollins sold 10,041 shares of the business's stock in a transaction on Friday, May 9th. The shares were sold at an average price of $30.70, for a total value of $308,258.70. Following the sale, the director owned 11,105 shares of the company's stock, valued at $340,923.50. The trade was a 47.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Randolph Altschuler sold 9,332 shares of the business's stock in a transaction on Wednesday, July 2nd. The stock was sold at an average price of $32.39, for a total transaction of $302,263.48. Following the completion of the sale, the chief executive officer directly owned 319,602 shares in the company, valued at approximately $10,351,908.78. This represents a 2.84% decrease in their position. The disclosure for this sale can be found here. Insiders own 9.66% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms recently issued reports on XMTR. JMP Securities raised their target price on shares of Xometry from $45.00 to $50.00 and gave the company a "market outperform" rating in a research note on Wednesday. Cantor Fitzgerald upgraded shares of Xometry from an "underweight" rating to a "neutral" rating and set a $41.00 price target on the stock in a research report on Tuesday. The Goldman Sachs Group raised their price target on shares of Xometry from $33.00 to $42.00 and gave the stock a "buy" rating in a research report on Wednesday. Royal Bank Of Canada raised their price target on shares of Xometry from $32.00 to $36.00 and gave the stock a "sector perform" rating in a research report on Wednesday, May 7th. Finally, UBS Group raised their price objective on shares of Xometry from $35.00 to $40.00 and gave the stock a "neutral" rating in a report on Wednesday. Three analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $40.44.
View Our Latest Research Report on Xometry
Xometry Profile
(
Free Report)
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
See Also

Before you consider Xometry, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.
While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.